Who is sponsoring NCT05377619?

NCT05377619 is sponsored by Universidade de Passo Fundo.

What drugs are being tested in NCT05377619?

Interventions: Prucalopride, Buspirone, Placebo.

What is the status of NCT05377619?

NCT05377619 is currently COMPLETED.

Last reviewed 2022-05-17 · How we verify

Preventing Gastric Glitch With Prucalopride and Buspirone: N-of-1 Clinical Trial

NCT05377619 PHASE1, PHASE2 COMPLETED

Background: Gastric glitch is a new functional disease characterized by severe and transient epigastric pain occurring after challenges such as drinking alcohol and eating specific foods. Aims: In this N-of-1 trial, we first characterized the clinical and gastric tomographic images of a patient with gastric glitch highly reproducible after alcohol challenging, and then tested the effect of prucalopride and buspirone on the prevention of gastric glitch crises.

Details

Lead sponsor	Universidade de Passo Fundo
Phase	PHASE1, PHASE2
Status	COMPLETED
Enrolment	1
Start date	Thu Jan 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sun Mar 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Dyspepsia

Interventions

Prucalopride
Buspirone
Placebo

Countries

Brazil